Haleon (LSE:HLN) Price-to-Tangible-Book : (As of Dec. 11, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Price-to-Tangible-Book?

As of today (2024-12-11), Haleon's share price is £3.79. Haleon's Tangible Book per Share of Jun. 2024 for the quarter that ended in Jun. 2024 was £-1.07. Hence, Haleon's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Haleon's Price-to-Tangible-Book or its related term are showing as below:

LSE:HLN's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.41
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Haleon's share price is £3.79. Haleon's Book Value per Sharefor the quarter that ended in Jun. 2024 was £1.82. Hence, Haleon's P/B Ratio of today is 2.08.

Haleon Price-to-Tangible-Book Historical Data

The historical data trend for Haleon's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Price-to-Tangible-Book Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Price-to-Tangible-Book	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Haleon's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haleon's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Haleon's Price-to-Tangible-Book falls into.

Haleon Price-to-Tangible-Book Calculation

Haleon's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2024 )
	=	3.79	/	-1.071
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Haleon Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Haleon's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (LSE:HLN) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLNl:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.